PARI Pharma is focused on new aerosol delivery technology and pharmaceutical formulation development together under one roof. PARI Pharma's core competencies include Advanced Aerosol Delivery Platform development, engineering, aerosol testing, product manufacturing, and medication formulation optimization for eFlow Technology devices.
Because eFlow Technology devices provide the potential for significantly reduced medication doses and treatment times, PARI Pharma is in the unique position of helping pharmaceutical companies develop innovative new medication formulations with customized drug-device matching. The potential for creating improved formulations, or new uses for approved active ingredients, is also greater with eFlow due to its innovative technology platform.
Primary Products: Advanced Aerosol Platforms including eFlow (Pulmonary) and Vibrent (Sinus) Technologies and formulations optimized for these platforms.